Radiology Devices Move To OIVD: More Cohesive Dx Reviews Ahead?

FDA hopes that shuttling its Radiological Devices Branch to the Office of In Vitro Diagnostic Device Evaluation and Safety will produce more cohesive policies on diagnostic device review

More from Archive

More from Medtech Insight